Delivery Order SPE2DB20D7061-SPE2DB24FSMS6

Award Date 3/19/24

Potential Completion Date 4/9/24

Potential Value $7.1K

Federal Agency

Defense Logistics Agency

Awardee

Amerisourcebergen Drug Corp KABZK8W6PQT3

Ultimate Awardee

Cencora, Inc. NWEGNLYTBDW4

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Conshohocken, PA 19428, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of the parent company Cencora, Inc. The $7,147.50 firm-fixed-price contract is for the supply of GAMUNEX-C, a 20-gram/200 ml vial of immunoglobulin G (IgG) medication. This award does not have a set-aside designation and has an ultimate completion date of April 9, 2024.

AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, AmerisourceBergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 11/1/24, 10:18 AM